Apic Bio Inc., of Cambridge, Mass., appointed Robert H. Brown Jr., R. Jude Samulski, Barry Byrne, Rob Kotin, Kevin Flanigan and Mark Kay to its scientific advisory board.
Arcutis Biotherapeutics Inc., of Westlake Village, Calif., appointed Patrick Burnett chief medical officer, effective Aug. 1. Howard Welgus was elected to its board.
Cidara Therapeutics Inc., of San Diego, appointed Frederick G. Hayden, Michael G. Ison, Johan A Maertens and Kieren Marr to its scientific advisory board.
Merus NV, of Utrecht, the Netherlands, appointed Andrew Joe chief medical officer.
Rhythm Pharmaceuticals Inc., of Boston, appointed Joseph Shulman senior vice president, technical operations.
Turning Point Therapeutics Inc., of San Diego, appointed Heather Adams vice president of human resources.